As a function of the restructuring of the company since the end of 2018, Integumen has delivered a nine fold increase in revenue in H1 2019.
OKYO Pharma (LON:OKYO) Raj Patil, Director of Research & Development Podcast
Dr. Raj Patil is Sr. Director of Research & Development at OKYO Pharma speaks to Zak Mir. Dr. Patil brings more than 25 years of academic and pharmaceutical experience in
Kunwar Shailubhai, CEO of Tiziana Life Sciences (NASDAQ:TLSA, AIM:TILS) Interview
Zak Mir speaks with Kunwar Shailubhai, CEO of Tiziana Life Sciences, are the markets, prospective investor understanding the business model?. As is often the case the focus is on a company
Fred Narbel, the new managing director of OptiBiotix Health PLC’s (LON:OPTI)
Proactive meets new director of OptiBiotix Health’s prebiotics division.
Integumen PLC (LON:SKIN) Gerry Brandon
Integumen PLC’s (LON:SKIN) Gerry Brandon caught up with Proactive London’s Andrew Scott to discuss three new contracts they’ve won worth £290,000 in total.
Integumen PLC (LON:SKIN) CEO Gerry Brandon ‘ move into clinical trials.
Integumen PLC (LON:SKIN) CEO Gerry Brandon speaks to Proactive London’s Andrew Scott soon after announcing the roll-out of a new Labskin test designed to clone the skin of volunteers in clinical
Tekcapital plc (LON:TEK) Salarius secures first commercial order
Salarius launches production of MicroSalt® and secures first commercial order
Leigh Hughes, chief executive of Next Green Wave Holdings Inc (CSE:NGW) Interview
Effective today, NGW will commence its cultivation program and receive its first plantlets to accommodate a perpetual harvest cycle.
Integumen PLC (LON:SKIN) Chief Executive Gerry Brandon
Integumen builds out Labskin AI platform with RinoCloud acquisition
ValiRx PLC (LON:VAL) Dr Satu Vainikka, CEO Interview
We caught up with Dr Satu Vainikka, CEO of VAL at this year UK Investors Show held in the QE2 building in London.
WideCells Group PLC (LON:WDC) New Media Business Created
New Media Business Created, Board Appointments and Proposed Name Change to Iconic Labs Plc
